[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 18, Issue 3 (10-2016) ::
J Gorgan Univ Med Sci 2016, 18(3): 40-44 Back to browse issues page
Additive effects of trans-resveratrol and imipramine to reduce depressive symptoms in the forced swimming test in mice
R Ataee * 1, AH Gitinavard2 , A Ataie3 , Y Nourian4 , M Shaterpour4
1- Assistant Professor, Talasemia Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran & Assistant Professor, Pharmaceutical Sciences Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran. , raminataee1349@gmail.com
2- Pharmacy Studen, Pharmaceutical Sciences Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran.
3- Assistant Professor, Department of Physiology and Pharmacology, Babol Universityof Medical Sciences, Babol, Iran.
4- M.Sc Student of Toxicology, Pharmaceutical Sciences Research Center, Mazandaran Universityof Medical Sciences, Sari, Iran.
Keywords: Depression, Resveratrol, Imipramine, Forced swimming test, Mouse
Full-Text [PDF 185 kb] [English Abstract]   (14079 Downloads)     |   Abstract (HTML)  (9889 Views)
Type of Study: Original Articles | Subject: Physiology - Pharmacology
Abstract:   (1261 Views)

Background and Objective: Resveratrol is a phenolic herbal compound which has been proposed as antioxidant in combinational therapy of diabetes, cancer and some neurodegenerative diseases. This study was done to evaluate additive effect of trans-resveratrol and imipramine to reduce depressive symptoms in the forced swimming test in mice.

Methods: In this experimental study, 56 Swiss Webster male mice were randomly allocated into 6 groups including negative control group (normal saline), positive control (imipramine (10 mg/kg/bw), experimental groups; trans resveratrol (10 mg/kg/bw), Imipiramine (10 mg/kg/bw) and mixtures (with ratio of 1:1 of resveratrol with imipramine (2.5 mg/kg/bw, 5 and 10 mg/kg/bw), intraperitoneally. The forced swimming test has been done for all groups. Through swimming of animals in water, the immobilization times of animals as depressive symptom were recorded.

Results: The immobilization times significantly reduced in animals which were received imipramine
10 mg/kg/bw in compare to control group (P<0.05). The immobilization times of animals were received resveratrol injection 10 mg/kg/bw with imipramine 10 mg/kg/bw was determined which it was significantly effective than imipramine10 mg/kg/bw, alone (P<0.05). The antidepressant effectiveness of resveratrol injection 5 mg/kg/bw is similar to resveratrol (2.5 mg/kg/bw) with imipramine (2.5mg/kg/bw). is similar to resveratrol (2.5 mg/kg) with imipramine (2.5 mg/kg/bw) (P<0.05). Also, antidepressant effect of intraperitoneal administration of resveratrol 10 mg/kg was significantly more than imipramine
10 mg/kg/bw (P<0.05).

Conclusion: According to additive effect of imipramine with resveratrol we can suggest resveratrol in combinations with other antidepressants to lower their doses and related side effects of chemical drugs.

References
1. Baldessarini RJ. Depression and Mania. In: Brunton L, Chabner B, Knollman B. Goodman and Gilman's the Pharmacological Basis of therapeutics. 20th ed. New York: Mc Graw Hill. 2001; pp: 431-59.
2. Carvalho AF, Berk M, Hyphantis TN, McIntyre RS. The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychother Psychosom. 2014; 83(2): 70-88. doi: 10.1159/000357500
3. Bogdanova OV, Kanekar S, D'Anci KE, Renshaw PF. Factors influencing behavior in the forced swim test. Physiol Behav. 2013; 118: 227-39. doi: 10.1016/j.physbeh.2013.05.012
4. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002 Dec; 958(2): 439-47.
5. Richard T, Pawlus AD, Iglésias ML, Pedrot E, Waffo-Teguo P, Mérillon JM, et al. Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci. 2011 Jan; 1215:103-8. doi: 10.1111/j.1749-6632.2010.05865.x
6. Jacobson JM. The relationship between social support and depression in adolescents. J Child Adolesc Psychiatr Nurs. 1991 Jan; 4(1): 20-24. doi: 10.1111/j.1744-6171.1991.tb00481.x
7. Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, et al. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacol. 2010 Jun; 20(6):405-13. doi: 10.1016/j.euroneuro.2010.02.013
8. Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl). 2008 Dec;201(3):435-42. doi: 10.1007/s00213-008-1300-y
9. Kulkarni S, Dhir A, Akula KK. Potentials of curcumin as an antidepressant. Scientific World Journal. 2009 Nov; 9:1233-41. doi: 10.1100/tsw.2009.137
10. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, et al. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol. 2005 Jul; 518(1):40-6.
11. Yu Y, Wang R, Chen C, Du X, Ruan L, Sun J, et al. Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences. J Psychiatr Res. 2013 Mar; 47(3):315-22. doi: 10.1016/j.jpsychires.2012.10.018
12. Huang W, Chen Z, Wang Q, Lin M, Wu S, Yan Q, et al. Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. Metab Brain Dis. 2013 Dec; 28(4):585-95. doi: 10.1007/s11011-013-9426-y
13. Wang Z, Gu J, Wang X, Xie K, Luan Q, Wan N, et al. Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacol Biochem Behav. 2013 Nov; 112:104-10. doi: 10.1016/j.pbb.2013.10.007
14. Huang J, Tufan T, Deng M, Wright G, Zhu MY. Corticotropin releasing factor up-regulates the expression and function of norepinephrine transporter in SK-N-BE (2) M17 cells. J Neurochem. 2015 Oct; 135(1):38-49. doi: 10.1111/jnc.13268
15. Satoh N, Toyohira Y, Takahashi K, Yanagihara N. Effects of various pharmacological agents on the function of norepinephrine transporter. J UOEH. 2015 Mar; 37(1):33-42. doi: 10.7888/juoeh.37.33
16. Matchkov VV, Kravtsova VV, Wiborg O, Aalkjaer C, Bouzinova EV. Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. Am J Physiol Regul Integr Comp Physiol. 2015 Oct; 309(8):R814-23. doi: 10.1152/ajpregu.00337.2014
17. Ge L, Zhu MM, Yang JY, Wang F, Zhang R, Zhang JH, et al. Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression. Pharmacol Biochem Behav. 2015 Apr; 131:77-86. doi: 10.1016/j. pbb.2015.01.017
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ataee R, Gitinavard A, Ataie A, Nourian Y, Shaterpour M. Additive effects of trans-resveratrol and imipramine to reduce depressive symptoms in the forced swimming test in mice. J Gorgan Univ Med Sci 2016; 18 (3) :40-44
URL: http://goums.ac.ir/journal/article-1-2835-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 18, Issue 3 (10-2016) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)